Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
about
Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug deliverySupramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble DrugsRecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingDrug Carriers: Not an Innocent Delivery ManThe janus facet of nanomaterialsZwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine releasePolymeric nanomedicine for cancer MR imaging and drug deliveryNanoparticle delivery and combination therapy of gambogic acid and all-trans retinoic acidNanopharmacology in translational hematology and oncologyApplication of chitosan-based nanocarriers in tumor-targeted drug delivery.Chitosan-based intelligent theragnosis nanocomposites enable pH-sensitive drug release with MR-guided imaging for cancer therapy.Preparation and evaluation of inhalable itraconazole chitosan based polymeric micellesGlycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.Recent advances of chitosan nanoparticles as drug carriersNanomedicine strategies for treatment of secondary spinal cord injury.Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.Chitosan functionalisation of gold nanoparticles encourages particle uptake and induces cytotoxicity and pro-inflammatory conditions in phagocytic cells, as well as enhancing particle interactions with serum componentsPolymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug deliverySubcellular Behaviour Evaluation of Nanopharmaceuticals with Aggregation-Induced Emission Molecules.Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.Polydopamine Nanoparticles as a Versatile Molecular Loading Platform to Enable Imaging-guided Cancer Combination Therapy.Lymphatic biodistribution of polylactide nanoparticles.Cancer therapies utilizing the camptothecins: a review of the in vivo literatureCancer Theranostic Nanoparticles Self-Assembled from Amphiphilic Small Molecules with Equilibrium Shift-Induced Renal Clearance.Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects.Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.Nanotechnology-based drug delivery systems and herbal medicines: a review.Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery.Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.Status of novel drug delivery technology for phytotherapeutics.pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers.Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.Cationic nanoparticles for cancer therapy.Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.Influence of nanotechnology on herbal drugs: A Review.
P2860
Q26766552-39FDE07A-A082-4148-B1B4-58FE9DE3F202Q26777831-C6707A35-D009-46E5-9423-AAB48BBD4F88Q26778234-5F8051DE-3207-46CF-88CD-594CE7F18038Q28082414-5C121C5C-7133-47A3-9541-AD25651CD739Q28083583-B4CAC510-F2D7-40CC-8B07-EC324B35A562Q28479064-9FDABA8B-934F-4F00-B66F-661B6F0D6784Q33773418-B6DB6421-64C2-4792-A879-6AD605A95840Q33904975-E0E62965-22FD-493F-9F9F-F7B2E555685FQ33961538-92E54BEF-E9CD-40F1-8CDB-B5E7D3644368Q34447152-58FC2686-B040-43AE-BE23-90E77F159FF5Q34481521-EAC8ADA6-1066-4768-9444-3486A1D87748Q34564171-6A8D81A6-ECED-406B-AEED-BEE21721F7A3Q34780593-532A2611-AE94-4126-AB17-8F63A15B99ACQ34956317-11D39F03-2522-4CE1-B343-E18A52BB218EQ35063603-0F8DA241-0467-40FB-BE26-BC353C3BD465Q35154383-77FF4693-FBF4-4AF0-A5A0-EE84DE7C04A5Q36201940-ED5D8C0D-6FD9-4464-B8B4-E03876F8705FQ36298604-8B429679-60E9-44C9-B711-0CF1C090388AQ36316919-7F30FECA-F59C-4E4F-B97F-950433005ACCQ36326103-0CAE2266-FDD8-4B1F-8492-4B3168ABEC42Q36367986-802037E3-7622-436B-A4BE-933048A2909FQ36738734-BBF290D7-6662-4208-A27E-A8768B2DB55BQ36752542-E1BD9B4D-EFAC-4B52-BA89-981BBA5B5B12Q36777292-43D55F26-C67D-4255-B95B-D918169BC594Q36926023-67D4643D-518E-4EE9-92C7-634675A52DD7Q36975890-BB28F205-D946-4C53-9DDC-A4CEBF2A0975Q37069556-E4680168-22FD-4DD6-A33E-339F6512E01AQ37112982-7DC05770-F774-445B-B009-80563396216FQ37148172-CCAEE770-17D6-4F79-99BE-E74F76DB2B40Q37229797-945A146D-70F2-4829-9961-6B868ED98104Q37391136-4BD63E07-CB54-4876-A2C1-1711CC5A592FQ37415357-6AF53075-0C06-4116-A353-EFBC01C330A0Q37444094-44C6EBD4-B724-4ED7-B9A3-404367415AB7Q37510870-369FFCDE-F000-4479-9A3F-E249A57A02D0Q37592063-CEF03F2D-DE48-4A56-BCB9-F1414ED332C2Q37729225-8398E0C5-8EAE-42C4-9372-BD9A6D9516B0Q37743515-8C8F0449-F447-4B46-A8AE-BA03D68FA344Q37788222-187F0558-D01D-4736-B174-DFF0A18B3EFCQ37938830-E42EE251-C754-4D11-AF6F-49131A002052Q38051359-F0695DDB-CBA2-4D53-8FD0-09A58DEB455A
P2860
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Hydrophobically modified glyco ...... r targeting in cancer therapy.
@en
type
label
Hydrophobically modified glyco ...... r targeting in cancer therapy.
@en
prefLabel
Hydrophobically modified glyco ...... r targeting in cancer therapy.
@en
P2093
P50
P1476
Hydrophobically modified glyco ...... r targeting in cancer therapy.
@en
P2093
Hyung Gon Jo
In-San Kim
Kyeongsoon Park
Kyung Hyun Min
Rang-Woon Park
Sang Mun Bae
Yoo-Shin Kim
P304
P356
10.1016/J.JCONREL.2008.01.013
P407
P577
2008-02-07T00:00:00Z